| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.063 | 0.1 |